Chronic Kidney Disease Diagnostics Market Introduction:

Chronic kidney disease symptoms like blood in urine, swollen joints, foamy urine, etc are seldom noticed by patients resulting in progressive loss of kidney functions and ultimately renal failure. Delayed diagnosis, lack of sufficient epidemiological data, the significant cost involved in end-stage renal diseases as well as mild kidney diseases have resulted in a substantial need for chronic kidney disease diagnostics. Apart from physical examination by healthcare professionals, certain diagnostics like biopsy or procedures like blood and urine test provide vital stats and early signs about patients neurological, blood vessels and organ conditions. Based on such diagnostic results healthcare professionals can effectively control the kidney symptoms and avoid the progression of chronic kidney disease in their patients.

Chronic Kidney Disease Diagnostics Market Overview

Factors boosting the chronic kidney disease diagnostics market:
•    Rising prevalence of kidney diseases
•    Increase in diabetic patients’ population 
•    Investments into R&D for kidney diseases diagnostic techniques
•    The ever-emerging healthcare sector 
•    Extensive use of processed food containing excess potassium and
•    The technological advancements in the healthcare diagnostics sector

Besides increased susceptibility of the ageing population due to degrading immune system, diabetics, cardiovascular issues are expected to fuel the growth of the global chronic kidney diseases diagnostics market during the forecast period.

North America holds the major revenue chunk in the global kidney diseases diagnostics market and is expected to grow at a thriving CAGR during the forecast period of 2019-2026. This is followed by Europe due to robust economic growth and investments in advanced diagnostic technologies. India, China and Vietnam from the APAC region are expected to demonstrate tremendous opportunities due to increased healthcare awareness, better household incomes and government aids to healthcare institutions. Rest of the world is expected to grow at a gradual CAGR and considerable market value in coming years. 

Key Market Players Abbott Laboratories, AbbVie Inc., Amgen Inc., Beckman Coulter, F. Hoffmann-La Roche Ltd, GlaxoSmithKline Plc, Pfizer Inc, Siemens Healthineers, Sysmex Corporation, Teva Pharmaceutical Industries Ltd.

Chronic Kidney Disease Diagnostics Market Segmentation:

By Product Type

• By Diagnosis
   o Blood Tests
   o Urine Tests
   o Imaging Tests
   o Others
• By Treatment
   o Drug Class

         o ACE Inhibitors
         o Angiotensin-II Receptor Blockers
         o Diuretics
      ​​​​​​​   o Other
​​​​​​​   o Dialysis​​​​​​​
​​​​​​​   o Other

By End-User

•    Hospitals
•    Clinics
•    Diagnostic labs 

By Region

•    North America
•    Latin America
•    Europe
•    Asia Pacific
•    Middle East and Africa

Competitive Landscape:  
•    Tier 1 players- established companies in the market with a major market share
•    Tier 2 players 
•    Emerging players which are growing rapidly 
•    New Entrants  

FutureWise Key Takeaways 
•    Growth prospects
•    SWOT analysis 
•    Key trends 
•    Key data-points affecting market growth 

Objectives of the Study: 
•    To provide with an exhaustive analysis on the global chronic kidney disease diagnostics market on the basis of product type, end user, and region
•    To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
•    To evaluate and forecast micro-markets and the overall market 
•    To predict the market size, in key regions (along with countries)—North America, Europe, Asia Pacific, Latin America, and Middle East and Africa
•    To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions
•    Profiling of companies to evaluate their market shares, strategies, financials and core competencies  

Flexible Delivery Model:
• We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
• The customization Mobility Care offered are free of charge with purchase of any license of the report
• You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com



Need Assistance


UK : +44 141 628 9353
US : +1 347 709 4931


Contact Sales

What you get

  • Excel Dataset

  • Infographics

  • PDF Report

  • Market Overview

  • PowerPoint Presentation

What's included

  • Consumer Perception and Procurement

  • Competitive Analysis

  • What’s Next

  • Market Data Forecast

  • Risks and Opportunity Assessment

  • Market Trends and Dynamics